Is Transcutaneous Carbon Monoxide Saturation of E-cigarette Users Comparable to That of Smokers? (COVAP)

Regional University Hospital Center (CHRU)

Status: Completed

Conditions: Carbon Monoxide Poisoning

Treatments: Other: Pulse CO-oximetry

Study type: Observational

Funder types: Other

Identifiers

NCT03669848

RIPH3-RNI18 / COVAP

2018-A01471-54 (Other Identifier)

Details and patient eligibility

About

Suspicions of carbon monoxide poisoning that lead to the treatment of victims are numerous. Measurement of transcutaneous carbon monoxide saturation (SpCO) is a useful diagnostic and triage tool for victims and the toxic threshold is clearly defined for both non-smokers (SpCO> 5%) and smokers ( SpCO> 10%).

Currently, the use of e-cigarettes is democratizing. Unfortunately, the threshold for toxic SpCO is not defined for this patient profile.

The risk is treating in excess or worse than underestimating carbon monoxide poisoning in e-cigarette users who would be exposed to carbon monoxide exposure.

Enrollment: 1,116 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Patient presenting to adult emergency department
• Age ≥ 18 years

Exclusion criteria

• Passive exposure to tobacco
• Mixed exposure (tobacco / e-cigarette)
• Patient having objected to the processing of his data

Trial design

1,116 participants in 1 patient group

Pulse CO-oximetry

Description:

Measuring blood Carbon Monoxide levels with Pulse CO-oximetry (SpCO) Measurements are taken with a noninvasive method by placing a sensor on a patient, usually on the fingertip.

Treatment:

Other: Pulse CO-oximetry